In 2007, lung cancer was responsible for 20.9% of all cancer-related deaths in Eastern Asia and 17.8% of all cancer-related deaths in South-Eastern Asia Lung cancer accounted for 17.1% of newly diagnosed cancer cases in Eastern Asia and 13.3% of newly diagnosed cancer cases in South-Eastern Asia in 2007 The incidence of lung cancer is predicted to increase substantially throughout Asia, particularly among males

Worldwide

It is estimated that 1,351,000 people worldwide die from lung cancer every year Around 80% of lung cancer patients have NSCLC and first present with advanced disease, which is difficult to treat Only 10% of lung cancer patients are alive 5 years after diagnosis, compared to 81% of melanoma and 75% of breast cancer patients At diagnosis, most patients with NSCLC present with advanced, inoperable (also called unresectable) disease, which is associated with poor prognosis Approximately 25 to 30% of cases are diagnosed as locally advanced disease (stage III) and 40 to 50% are diagnosed as metastatic disease (stage IV) merck.de/